Olon Biotech division launched
Italian firm Olon has presented its new division, Olon Biotech, which will offer CDMO services at industrial scale. These based on microbial fermentation processes using bacteria, yeast and fungi and will include high potency. It will also have proprietary products for industries including health and pharma, food, cosmetics, flavours and fragrances.
Olon Biotech is based around the two multi-purpose ‘bio-hubs’ at Settimo Torinese and Capua, in which the company has invested around €80 million in recent years. This, the firm said, has led significant increase in capacity and added new purifications departments. Some 675 people work in these bio-hubs.
RELATED ARTICLES
The US Environmental Protection Agency (EPA) has taken two separate actions on per- and polyfluorinated substances (PFAS), both being part of its PFAS strategic roadmap, which aims to implement legislation by Q4 to reduce and destroy PFAS contamination in water, air and soil.
The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on hum
Lubrizol has opened a new Global Capability Centre (GCC) in Pune, India, as “a strategic hub to accelerate its growth in the region and enable closer collaboration for its customers and employees”.
International Process Plants (IPP), which buys and sells industrial plants and equipment, has acquired Henkel’s detergent plant in Lomazzo, Italy, in partnership with Maynards, a specialist in industrial liquidation auction services.
Chemours has completed its planned procedures with respect to an internal review that it first announced on 29 February. This essentially confirmed the details revealed in an interim report on 7 March.
Symrise and India’s Virchow Group have agreed to make personal care ingredients from the Symrise portfolio through a new joint venture called Vizag Care Ingredients, beginning within 1H. This will be based on Virchow’s synthetic chemistry capabilities for API manufacture.
